News
Eli Lilly (NYSE:LLY) is a pharmaceutical titan with an $815 billion market cap, putting it on track to be the next $1 ...
Shares in pharmaceuticals giant Eli Lilly (LLY) were looking perkier today after it ramped up its battle to get a key ...
Xylazine, an animal tranquilizer also referred to as the "zombie drug," is sometimes found mixed with illegal opioid drugs and has "gruesome" side effects. Other pharma news is on quitting vaping, ...
NBC 26 WGBA Green Bay, WI on MSN3d
Breaking down the 2025 NFL Draft mapWe took a look at the 2025 NFL Draft campus map, pointing out some of the key features to know.
A wildfire in Pennsylvania has burned hundreds of acres and is moving closer to people's homes as firefighters work to contain it. The Packerton Fire, which is also known as the Jim Thorpe Fire or ...
Moses Brown’s Lilly Madeira earning recognition for this week’s ABC6 Sports Play of the Week. The senior committed to ...
Eli Lilly & Co. plans to manufacture its new weight-loss pill in the US for patients around the world as President Donald ...
When I started taking a GLP-1 medication in October, I knew it would probably change a few things—our weekly dinner plan, how ...
Precision Neuroscience announced that a core component of its brain implant system has been approved by the FDA.
Woodblock prints with Buddhist and Daoist imagery, the Gutenberg Bible with moveable type, books containing multiple ...
In an interview, the US pharmaceuticals giant’s international chief says Australia has made no progress in making life easier for medicine developers.
Eli Lilly and Company traded as low as $718.81 and last traded at $718.89. Approximately 663,002 shares changed hands during trading, a decline of 80% from the average daily volume of 3,354,701 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results